Related Experiment Video
Updated: Jan 19, 2026

A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate NMDA Receptor in Blood
Published on: January 9, 2018
Anti-NMDA receptor encephalitis: a case study and illness overview
Brian Ford1, Alex McDonald2, Shilpa Srinivasan3
1PGY-4 Resident Psychiatrist, Palmetto Health-University of South Carolina Psychiatry Residency Program, Columbia, South Carolina, USA.
Anti-N-methyl D-aspartate receptor (anti-NMDAR) encephalitis can mimic psychiatric disorders, delaying diagnosis. Early detection through cerebrospinal fluid (CSF) antibody testing and prompt immunotherapy are crucial for managing this autoimmune condition.
Area of Science:
- Neurology
- Immunology
- Psychiatry
Background:
- Anti-N-methyl D-aspartate receptor (anti-NMDAR) encephalitis is a common autoimmune neurological disorder.
- Its varied clinical presentation and complex course can lead to diagnostic delays.
- The mild encephalitis (ME) hypothesis links neuroinflammation in anti-NMDAR encephalitis to psychiatric disorders like schizophrenia.
Purpose of the Study:
- To highlight the diagnostic challenges of anti-NMDAR encephalitis.
- To emphasize the overlap in symptoms with psychiatric conditions.
- To review diagnostic methods and management strategies.
Main Methods:
- Clinical evaluation including neurological and psychiatric assessments.
- Cerebrospinal fluid (CSF) analysis for antibodies, pleocytosis, and oligoclonal bands.
- Serum antibody testing for anti-NMDAR antibodies.
Main Results:
- Anti-NMDAR encephalitis symptoms can mimic schizophrenia and other psychotic disorders.
- CSF assays are more sensitive than serum assays for diagnostic confirmation.
- The condition affects all ages, predominantly females, and can occur without paraneoplastic association.
Conclusions:
- Early diagnosis of anti-NMDAR encephalitis is critical due to its potential mimicry of psychiatric disorders.
- CSF antibody testing is essential for confirming the diagnosis.
- Treatment involves symptomatic management and immunotherapy.
More Related Videos
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
06:42Application of a NMDA Receptor Conductance in Rat Midbrain Dopaminergic Neurons Using the Dynamic Clamp Technique
Published on: December 21, 2010
Related Concept Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
06:42Application of a NMDA Receptor Conductance in Rat Midbrain Dopaminergic Neurons Using the Dynamic Clamp Technique
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
04:23A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists